Follow
"Their core finding is that eliminating adrenoceptor β1 (ADRB1) from T cells, or globally blocking ADRB1 with beta-blockers, enhances the capacity of T cells to secrete effector molecules and cytokines and increases effector capacity in chronic infections and tumors."
